Home NDC 0310-9501-04 TRUQAP
Product NDC 0310-9501
Requested package NDC 0310-9501-04
11-digit product format 003109501
Labeler code 0310
Product ID 0310-9501_6fe78f1e-417a-4ca4-8543-2e90c7b5ac29
Type HUMAN PRESCRIPTION DRUG
Nonproprietary name capivasertib
Dosage form TABLET, FILM COATED
Route ORAL
Labeler AstraZeneca Pharmaceuticals LP
Application NDA218197
Marketing category NDA
Marketing start 2023-11-16
Substance CAPIVASERTIB
Active strength 200 mg/1
NDC exclude flag No
Listing certified through 2027-12-31
Current FDA listing Yes Source provenance: Browse the complete Orange Book source catalog · source snapshot 45 .
Orange Book products# Current product rows page 1 of 1 · 2 matching rows.
Application-product, Trade name, Ingredient table Application-product Trade name Ingredient Strength Dosage form / route TE codes RLD / RS Approval date N218197-001 TRUQAP CAPIVASERTIB 160MG TABLET / ORAL RLD 2023-11-16 N218197-002 TRUQAP CAPIVASERTIB 200MG TABLET / ORAL RLD, RS 2023-11-16
Orange Book patents# Current patent rows page 1 of 1 · 20 matching rows.
Application-product, Patent, Expiration table Application-product Patent Expiration Use code Coverage / status Submission date N218197-001 10059714 2028-10-10 Drug substance, Drug product 2023-12-13 N218197-001 10654855 2028-10-10 U-3762 2023-12-13 N218197-001 11236095 2028-10-10 U-4559 2026-07-07 N218197-001 11760760 2028-10-10 U-3762 2023-12-13 N218197-001 12252495 2028-10-10 U-3762 2025-03-28 N218197-001 9492453 2028-10-10 U-4559 2026-07-07 N218197-001 8101623 2030-03-10 U-3762 Drug substance, Drug product 2023-12-13 N218197-001 10039766 2033-04-16 U-3762 2023-12-13 N218197-001 10039766 2033-04-16 U-4559 2023-12-13 N218197-001 9487525 2033-04-16 Drug substance, Drug product 2023-12-13 N218197-002 10059714 2028-10-10 Drug substance, Drug product 2023-12-13 N218197-002 10654855 2028-10-10 U-3762 2023-12-13 N218197-002 11236095 2028-10-10 U-4559 2026-07-07 N218197-002 11760760 2028-10-10 U-3762 2023-12-13 N218197-002 12252495 2028-10-10 U-3762 2025-03-28 N218197-002 9492453 2028-10-10 U-4559 2026-07-07 N218197-002 8101623 2030-03-10 U-3762 Drug substance, Drug product 2023-12-13 N218197-002 10039766 2033-04-16 U-3762 2023-12-13 N218197-002 10039766 2033-04-16 U-4559 2023-12-13 N218197-002 9487525 2033-04-16 Drug substance, Drug product 2023-12-13
Orange Book exclusivity# Current exclusivity rows page 1 of 1 · 4 matching rows.
Observed Orange Book product history# Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
Product history page 1 of 2 · 44 observed states.
Captured, Edition, Application-product table Captured Edition Application-product Trade name Strength Dosage form / route Product TE source text RLD / RS Approval date Source SHA-256 2026-11-14 07:37:17 2026-10 N218197-001 TRUQAP 160MG TABLET / ORAL RLD 2023-11-16 d4dbc9d85df4…2026-11-14 07:37:17 2026-10 N218197-002 TRUQAP 200MG TABLET / ORAL RLD, RS 2023-11-16 d4dbc9d85df4…2026-10-15 13:18:30 2026-09 N218197-001 TRUQAP 160MG TABLET / ORAL RLD 2023-11-16 c2088c7a36db…2026-10-15 13:18:30 2026-09 N218197-002 TRUQAP 200MG TABLET / ORAL RLD, RS 2023-11-16 c2088c7a36db…2026-09-14 22:38:34 2026-08 N218197-001 TRUQAP 160MG TABLET / ORAL RLD 2023-11-16 84e616aacf4f…2026-09-14 22:38:34 2026-08 N218197-002 TRUQAP 200MG TABLET / ORAL RLD, RS 2023-11-16 84e616aacf4f…2026-08-18 06:07:40 2026-07 N218197-001 TRUQAP 160MG TABLET / ORAL RLD 2023-11-16 caaa826d4ba7…2026-08-18 06:07:40 2026-07 N218197-002 TRUQAP 200MG TABLET / ORAL RLD, RS 2023-11-16 caaa826d4ba7…2026-02-19 14:30 UTC 2026-02 N218197-001 TRUQAP 160MG TABLET / ORAL RLD 2023-11-16 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N218197-002 TRUQAP 200MG TABLET / ORAL RLD, RS 2023-11-16 011fe1cb6892…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N218197-001 TRUQAP 160MG TABLET / ORAL RLD 2023-11-16 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N218197-002 TRUQAP 200MG TABLET / ORAL RLD, RS 2023-11-16 31067a03dcf5…2025-08-23 18:47 UTC 2025-08 N218197-001 TRUQAP 160MG TABLET / ORAL RLD 2023-11-16 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 N218197-002 TRUQAP 200MG TABLET / ORAL RLD, RS 2023-11-16 6a471c1ec25d…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 N218197-001 TRUQAP 160MG TABLET / ORAL RLD 2023-11-16 fd3edfee7708…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 N218197-002 TRUQAP 200MG TABLET / ORAL RLD, RS 2023-11-16 fd3edfee7708…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 N218197-001 TRUQAP 160MG TABLET / ORAL RLD 2023-11-16 b8a1b40f171c…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 N218197-002 TRUQAP 200MG TABLET / ORAL RLD, RS 2023-11-16 b8a1b40f171c…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 N218197-001 TRUQAP 160MG TABLET / ORAL RLD 2023-11-16 03ed91905a0d…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 N218197-002 TRUQAP 200MG TABLET / ORAL RLD, RS 2023-11-16 03ed91905a0d…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 N218197-001 TRUQAP 160MG TABLET / ORAL RLD 2023-11-16 2680178bc6a6…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 N218197-002 TRUQAP 200MG TABLET / ORAL RLD, RS 2023-11-16 2680178bc6a6…2024-09-14 05:58 UTC · 2 captures of this ZIP 2024-09 N218197-001 TRUQAP 160MG TABLET / ORAL RLD 2023-11-16 5bbf6a4d5a75…2024-09-14 05:58 UTC · 2 captures of this ZIP 2024-09 N218197-002 TRUQAP 200MG TABLET / ORAL RLD, RS 2023-11-16 5bbf6a4d5a75…2024-11-08 22:44 UTC · 3 captures of this ZIP 2024-11 N218197-001 TRUQAP 160MG TABLET / ORAL RLD 2023-11-16 d8e5a09893c0…2024-11-08 22:44 UTC · 3 captures of this ZIP 2024-11 N218197-002 TRUQAP 200MG TABLET / ORAL RLD, RS 2023-11-16 d8e5a09893c0…2024-10-29 15:01 UTC 2024-10 N218197-001 TRUQAP 160MG TABLET / ORAL RLD 2023-11-16 d06236e962d9…2024-10-29 15:01 UTC 2024-10 N218197-002 TRUQAP 200MG TABLET / ORAL RLD, RS 2023-11-16 d06236e962d9…2024-08-13 05:28 UTC · 3 captures of this ZIP 2024-08 N218197-001 TRUQAP 160MG TABLET / ORAL RLD 2023-11-16 79d66fd596c7…2024-08-13 05:28 UTC · 3 captures of this ZIP 2024-08 N218197-002 TRUQAP 200MG TABLET / ORAL RLD, RS 2023-11-16 79d66fd596c7…2024-07-13 05:37 UTC · 2 captures of this ZIP 2024-07 N218197-001 TRUQAP 160MG TABLET / ORAL RLD 2023-11-16 301d65b070ca…2024-07-13 05:37 UTC · 2 captures of this ZIP 2024-07 N218197-002 TRUQAP 200MG TABLET / ORAL RLD, RS 2023-11-16 301d65b070ca…2024-06-18 03:08 UTC · 5 captures of this ZIP 2024-06 N218197-001 TRUQAP 160MG TABLET / ORAL RLD 2023-11-16 1e350fbaab3a…2024-06-18 03:08 UTC · 5 captures of this ZIP 2024-06 N218197-002 TRUQAP 200MG TABLET / ORAL RLD, RS 2023-11-16 1e350fbaab3a…2024-05-31 18:47 UTC 2024-05 N218197-001 TRUQAP 160MG TABLET / ORAL RLD 2023-11-16 8072bd15b7f6…2024-05-31 18:47 UTC 2024-05 N218197-002 TRUQAP 200MG TABLET / ORAL RLD, RS 2023-11-16 8072bd15b7f6…2024-03-16 18:09 UTC · 4 captures of this ZIP 2024-03 N218197-001 TRUQAP 160MG TABLET / ORAL RLD 2023-11-16 6a51e52b5d6a…2024-03-16 18:09 UTC · 4 captures of this ZIP 2024-03 N218197-002 TRUQAP 200MG TABLET / ORAL RLD, RS 2023-11-16 6a51e52b5d6a…2024-02-18 07:12 UTC 2024-02 N218197-001 TRUQAP 160MG TABLET / ORAL RLD 2023-11-16 1c564ffb4f44…2024-02-18 07:12 UTC 2024-02 N218197-002 TRUQAP 200MG TABLET / ORAL RLD, RS 2023-11-16 1c564ffb4f44…
Observed Orange Book patent history# Patent history page 1 of 9 · 358 observed states.
Captured, Edition, Application-product table Captured Edition Application-product Patent Expiration Use code Coverage / status Submission date Source SHA-256 2026-11-14 07:37:17 2026-10 N218197-001 10059714 2028-10-10 Drug substance, Drug product 2023-12-13 d4dbc9d85df4…2026-11-14 07:37:17 2026-10 N218197-001 10654855 2028-10-10 U-3762 2023-12-13 d4dbc9d85df4…2026-11-14 07:37:17 2026-10 N218197-001 11236095 2028-10-10 U-4559 2026-07-07 d4dbc9d85df4…2026-11-14 07:37:17 2026-10 N218197-001 11760760 2028-10-10 U-3762 2023-12-13 d4dbc9d85df4…2026-11-14 07:37:17 2026-10 N218197-001 12252495 2028-10-10 U-3762 2025-03-28 d4dbc9d85df4…2026-11-14 07:37:17 2026-10 N218197-001 9492453 2028-10-10 U-4559 2026-07-07 d4dbc9d85df4…2026-11-14 07:37:17 2026-10 N218197-001 8101623 2030-03-10 U-3762 Drug substance, Drug product 2023-12-13 d4dbc9d85df4…2026-11-14 07:37:17 2026-10 N218197-001 10039766 2033-04-16 U-3762 2023-12-13 d4dbc9d85df4…2026-11-14 07:37:17 2026-10 N218197-001 10039766 2033-04-16 U-4559 2023-12-13 d4dbc9d85df4…2026-11-14 07:37:17 2026-10 N218197-001 9487525 2033-04-16 Drug substance, Drug product 2023-12-13 d4dbc9d85df4…2026-11-14 07:37:17 2026-10 N218197-002 10059714 2028-10-10 Drug substance, Drug product 2023-12-13 d4dbc9d85df4…2026-11-14 07:37:17 2026-10 N218197-002 10654855 2028-10-10 U-3762 2023-12-13 d4dbc9d85df4…2026-11-14 07:37:17 2026-10 N218197-002 11236095 2028-10-10 U-4559 2026-07-07 d4dbc9d85df4…2026-11-14 07:37:17 2026-10 N218197-002 11760760 2028-10-10 U-3762 2023-12-13 d4dbc9d85df4…2026-11-14 07:37:17 2026-10 N218197-002 12252495 2028-10-10 U-3762 2025-03-28 d4dbc9d85df4…2026-11-14 07:37:17 2026-10 N218197-002 9492453 2028-10-10 U-4559 2026-07-07 d4dbc9d85df4…2026-11-14 07:37:17 2026-10 N218197-002 8101623 2030-03-10 U-3762 Drug substance, Drug product 2023-12-13 d4dbc9d85df4…2026-11-14 07:37:17 2026-10 N218197-002 10039766 2033-04-16 U-3762 2023-12-13 d4dbc9d85df4…2026-11-14 07:37:17 2026-10 N218197-002 10039766 2033-04-16 U-4559 2023-12-13 d4dbc9d85df4…2026-11-14 07:37:17 2026-10 N218197-002 9487525 2033-04-16 Drug substance, Drug product 2023-12-13 d4dbc9d85df4…2026-10-15 13:18:30 2026-09 N218197-001 10059714 2028-10-10 Drug substance, Drug product 2023-12-13 c2088c7a36db…2026-10-15 13:18:30 2026-09 N218197-001 10654855 2028-10-10 U-3762 2023-12-13 c2088c7a36db…2026-10-15 13:18:30 2026-09 N218197-001 11236095 2028-10-10 U-4559 2026-07-07 c2088c7a36db…2026-10-15 13:18:30 2026-09 N218197-001 11760760 2028-10-10 U-3762 2023-12-13 c2088c7a36db…2026-10-15 13:18:30 2026-09 N218197-001 12252495 2028-10-10 U-3762 2025-03-28 c2088c7a36db…2026-10-15 13:18:30 2026-09 N218197-001 9492453 2028-10-10 U-4559 2026-07-07 c2088c7a36db…2026-10-15 13:18:30 2026-09 N218197-001 8101623 2030-03-10 U-3762 Drug substance, Drug product 2023-12-13 c2088c7a36db…2026-10-15 13:18:30 2026-09 N218197-001 10039766 2033-04-16 U-3762 2023-12-13 c2088c7a36db…2026-10-15 13:18:30 2026-09 N218197-001 10039766 2033-04-16 U-4559 2023-12-13 c2088c7a36db…2026-10-15 13:18:30 2026-09 N218197-001 9487525 2033-04-16 Drug substance, Drug product 2023-12-13 c2088c7a36db…2026-10-15 13:18:30 2026-09 N218197-002 10059714 2028-10-10 Drug substance, Drug product 2023-12-13 c2088c7a36db…2026-10-15 13:18:30 2026-09 N218197-002 10654855 2028-10-10 U-3762 2023-12-13 c2088c7a36db…2026-10-15 13:18:30 2026-09 N218197-002 11236095 2028-10-10 U-4559 2026-07-07 c2088c7a36db…2026-10-15 13:18:30 2026-09 N218197-002 11760760 2028-10-10 U-3762 2023-12-13 c2088c7a36db…2026-10-15 13:18:30 2026-09 N218197-002 12252495 2028-10-10 U-3762 2025-03-28 c2088c7a36db…2026-10-15 13:18:30 2026-09 N218197-002 9492453 2028-10-10 U-4559 2026-07-07 c2088c7a36db…2026-10-15 13:18:30 2026-09 N218197-002 8101623 2030-03-10 U-3762 Drug substance, Drug product 2023-12-13 c2088c7a36db…2026-10-15 13:18:30 2026-09 N218197-002 10039766 2033-04-16 U-3762 2023-12-13 c2088c7a36db…2026-10-15 13:18:30 2026-09 N218197-002 10039766 2033-04-16 U-4559 2023-12-13 c2088c7a36db…2026-10-15 13:18:30 2026-09 N218197-002 9487525 2033-04-16 Drug substance, Drug product 2023-12-13 c2088c7a36db…
Observed Orange Book exclusivity history# Exclusivity history page 1 of 2 · 52 observed states.
Reported adverse events (FAERS/openFDA)# Adverse event summaries are temporarily unavailable. Other product information remains available.
Additional Listing Data#
Finished product Yes
Brand name base TRUQAP
Listing expiration 2027-12-31 Active Ingredients# Ingredient, Strength table Ingredient Strength CAPIVASERTIB 200 mg/1
Harmonized UNII identifiers# UNII identifiers page 1 of 1 · 1 matching rows.
Identifier, FDA.report destination table Identifier FDA.report destination WFR23M21IE Internal UNII lookup
Harmonized RxCUI identifiers# RxCUI identifiers page 1 of 1 · 4 matching rows.
Identifier, FDA.report destination table Identifier FDA.report destination 2669972 Internal RxNorm lookup 2669978 Internal RxNorm lookup 2669980 Internal RxNorm lookup 2669982 Internal RxNorm lookup
Harmonized SPL set identifiers# SPL set identifiers page 1 of 1 · 1 matching rows.
DailyMed Product Concepts# DailyMed Package Descriptions# Package NDC, Product, Description table Package NDC Product Description Form Quantity Strength SPL version 0310-9501-01 TRUQAP 64 in 1 BOTTLE TABLET, FILM COATED 64 8 0310-9501-02 TRUQAP 16 in 1 BLISTER PACK TABLET, FILM COATED 16 8 0310-9501-02 TRUQAP 4 in 1 CARTON TABLET, FILM COATED 4 8 0310-9501-95 TRUQAP 64 in 1 BOTTLE TABLET, FILM COATED 64 8 0310-9501-96 TRUQAP 4 in 1 CARTON TABLET, FILM COATED 4 8 0310-9501-96 TRUQAP 16 in 1 BLISTER PACK TABLET, FILM COATED 16 8
DailyMed Dashboard NDC Coverage# NDC, Dashboard title, SPL version table NDC Dashboard title SPL version Validation Dashboard ZIP 0310-9501 TRUQAP (CAPIVASERTIB) TABLET, FILM COATED [ASTRAZENECA PHARMACEUTICALS LP] 7 Current NDC, 6 package rows 20250226_d698c106-2322-401e-b738-cbd83c843ecf.zip
openFDA label cross-check# OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
Matched openFDA labels page 1 of 1 · 1 matching rows.
Packages# Package NDC, 11-digit format, Description table Package NDC 11-digit format Description Units Marketing start Sample Exclude flag Status 0310-9501-04 00310950104 4 BLISTER PACK in 1 CARTON (0310-9501-04) / 8 TABLET, FILM COATED in 1 BLISTER PACK 4 blister pack 2026-06-03 No No Current